The outbreak of the COVID-19 pandemic in the world has led to a rise in falsified drugs entering the supply chain, thus putting public health at risk in domestic as well as global markets. The global anti-counterfeit pharmaceutical packaging market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2 per cent in the forecast period of 2020 to 2025 and will be expected to reach $124.5m by 2025, from $97.7m in 2019.
According to a report, £9.2bn has been lost through intellectual property (IP) theft, £7.6bn to industrial espionage and £2.2bn from extortion.
Anti-counterfeit packaging market size will be worth up to $184.87bn by 2025. Track and trace technology products are expected to grow at a CAGR of over nine per cent by revenue from 2016 to 2025, driven by the superior product detection and tracking through the supply chain. The track and trace solutions market will be worth $3.93bn USD by 2023.
The major markets for pharmaceuticals have been forever transformed with the arrival of mandated serialisation. With both the United States Drug Supply Chain Security Act (DSCSA) and European Union Falsified Medicines Directive (FMD) now “live”, the pharmaceutical supply chain is forever tied to serialised products and data.
This conference overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines.
In addition to discussion of the problems, this conference addresses serialisation, track and trace analytical techniques scientists use to detect counterfeits, and identifying solutions to the threat of counterfeit medical products.
It gives us immense pleasure in welcoming you to Virtue Insight’s – “9th Annual Pharma AntiCounterfeiting & Serialisation 2021 – “Competences to Combat Counterfeits” event.